Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study

BMC Infect Dis. 2020 Oct 31;20(1):806. doi: 10.1186/s12879-020-05541-2.

Abstract

Background: This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015-16.

Methods: The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11,988 prisoners selected from among 55 prisons in 19 provinces in 2015-16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes.

Results: The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52 and 2.46%, respectively. The prevalence of HCV was associated with age ≥ 30 years, being single, illiteracy and low level of education, prison term> 5 years, history of piercing, and extramarital sex in lifetime (P < 0.05).

Conclusions: The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.

Keywords: HBV; HCV; Iran; PWID; Prevalence; Prison.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • Hepacivirus
  • Hepatitis B / complications
  • Hepatitis B / epidemiology*
  • Hepatitis B / prevention & control
  • Hepatitis B virus
  • Hepatitis C / complications
  • Hepatitis C / epidemiology*
  • Hepatitis C / prevention & control
  • Humans
  • Iran / epidemiology
  • Logistic Models
  • Male
  • Prevalence
  • Prisoners* / statistics & numerical data
  • Prisons
  • Risk Factors
  • Substance Abuse, Intravenous / complications*
  • Viral Hepatitis Vaccines / administration & dosage

Substances

  • Viral Hepatitis Vaccines